Personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial.
Source: Bohingamu Mudiy-anselage, S., et al. 2019 - Pubmed ID: 29793387
Setting: Australia, Regional health service center
RCT
Follow up: 12 months
Sample size:
Total: 177 (163)
IG: 88 (83)
CG: 89(80)
Inclusion criteria:
- Diabetes and/or chronic obstructive pulmonary disease (COPD)
- High risk for readmission
Home monitoring
- Tablet
- Peripheral monitoring equipment
Videoconsultation
- Health coaching
Webpage
- Remote Patient Monitoring from TELUS®
Intervention: Patient collect biometric readings and enter daily answers to health questionnaire. Nurses and specialist consultant provide an individualized care plan with upper and lower limits on individual parameters. Nurses identify when data are outside threshold and respond to pt.
Duration: 12 months
Add on: NA
Control group: Usual care
Clinical effect:
- Blood pressure →
- HbA1c →
- Total cholesterol →
- Triglyceride →
- Microalbumin ↓
- GAD-7, anxiety↓(improved)
- PHQ-9 depression ↓(improved)
- Health literacy domains (HeiQ): 4/8 domains ↑ (improvement)
Patient safety: NA
Patient experiences: NA
Staff experiences: NA
Investment:
Material
- Monitoring equipment
- Remote Patient Monitoring platform from TELUS®
Running:
Staff resources
- Monitoring patient data
- On call staff
- Patient coaching sessions
Organization:
- Written or telephone contact with primary care (GP)
Health care utilization:
- Hospital admissions →
- Mean hospital length of stay → (acute admissions ↓)
- Mean hospital cost ↓